Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Martine E D Chamuleau*, Coreline N Burggraaff, Marcel Nijland, Katerina Bakunina, Rogier Mous, Pieternella J Lugtenburg, Daan Dierickx, Gustaaf W van Imhoff, Joost S P Vermaat, Erik A F Marijt, Otto Visser, Caroline Mandigers, Yavuz M Bilgin, Aart Beeker, Mark F Durian, Bas van Rees, Lara H Bohmer, Lidwine W Tick, Rinske S Boersma, Tjeerd J F SnijdersHarry C Schouten, Harry R Koene, Eva de Jongh, Nathalie Hijmering, Arjan Diepstra, Anke van den Berg, Anne I J Arens, Julia Huijbregts, Otto Hoekstra, Josee M Zijlstra, Daphne de Jong, Marie José Kersten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2805-2812
Number of pages8
JournalHaematologica-the Hematology Journal
Volume105
Issue number12
Early online date19 Dec 2019
DOIs
Publication statusPublished - Dec 2020

Keywords

  • DOUBLE-HIT LYMPHOMA
  • BONE-MARROW INVOLVEMENT
  • NON-HODGKIN-LYMPHOMA
  • RESPONSE ASSESSMENT
  • POOR-PROGNOSIS
  • FDG PET/CT
  • SUBTYPES
  • OUTCOMES

Cite this